RT Journal Article
SR Electronic
T1 Atherogenic sdLDL-cholesterol and resistin association with vitamin B12 in relation to Body Mass Index
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.08.24300967
DO 10.1101/2024.01.08.24300967
A1 Ashfaq, Fauzia
A1 Haji Alhaji, Jwaher
A1 Alharbi, Mohammed Salem
A1 Khatoon, Fahmida
A1 Alhatlani, Nayef Hamad E
A1 Mari Alkhamisi, Fahad Ayash
A1 Alshuwaier, Ghareeb O.
A1 Khan, Mohammad Idreesh
A1 Beg, Mirza Masroor Ali
YR 2024
UL http://medrxiv.org/content/early/2024/01/09/2024.01.08.24300967.abstract
AB Introduction Obesity is a known risk factor for many chronic diseases and is a growing global health concern and poor health outcomes have consistently been linked to body mass index (BMI). Small dense low-density lipoprotein (sdLDL) changes brought on by obesity may increase the likelihood of endothelium penetration and subsequent atherogenesis. Numerous tissues’ metabolic and secretory functions are altered by obesity, which may also increase the serum resistin level.Methods Present study included 300 participants with diffent BMI among them sdLDL and resistin was evaluated. HbA1c was analysed by whole blood of EDTA and the serum were thawed sample was used for lipid parameters (TG, cholesterol, HDL, LDL, VLDL and sdLDL) and vitamin B12 analysis as well as resistin level was analysed by ELISA.Results Study observed higher HbA1c (%, p=0.0004), LDL (mg/dl) (<0.0001), TG (mg/dl) (<0.0001), Cholesterol (mg/dl) (<0.0001), VLDL (mg/dl) (<0.0001) in obese compared to overweight, normal BMI, except HDL. Smokers and hypertensive participants had higher sdLDL (p=0.03, p=0.0001) and resistin level (p=0.03, p<0.0001). Obese participants had high amount of sdLDL (p<0.0001, p<0.0001) and resistin level (p<0.0001, p<0.0001) compared to overweight and normal BMI. SdLDL and resistin were found to be positively correlated as well as correlation analysis of sdLDL and resistin level was observed to be significantly correlated with BMI, systolic, TG, cholesterol, VLDL, LDL while negative correlation with HDL level. ROC analysis showed that sdLDL and resistin could be used as prognostic factor for overweight/obesity at cutoff value of 18.55 mg/dl (sdLDL) and 750 pg/ml (resistin). It was also observed that the participant with normal BMI had 389.6 pmol/L while overweight participant had 300.6 pmol/L (p<0.0001) and obese had 291.0 pmol/L (p<0.0001).Conclusion Study concluded that the obese participants had higher TG, cholesterol, VLDL, LDL and lower HDL level. The most importantly, higher sdLDL level and resistin level was observed in obese participants as well as higher sdLDL and resistin could influence the higher lipid parameters (TG, cholesterol, VLDL, LDL) and lower HDL level. It was also observed that obese participants had lower vitamin B12 level and could lead to other metabolic error.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research ethics committee University of Hail and Ministry of health ethics committee gave their approval to this studyI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesWe confirm that the data used during the research will not be shared with anybody/broadcasted in any public domain. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.